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Abstract
Background: As several studies have shown an association between periodontal disease and chronic kidney
disease (CKD), regular dental care may be an important strategy for reducing the burden of CKD. Access to dental
care may be limited in the US public health system.
Methods: In this retrospective cohort study of 6,498 adult patients with (n = 2,235) and without (n = 4,263) CKD
and at least 12 months of follow-up within the San Francisco Department of Public Health Community Health
Network clinical databases, we examined the likelihood of having a dental visit within the observation period
(2005-2010) using Cox proportional hazards models. To determine whether dental visits reflected a uniform
approach to preventive service use in this setting, we similarly examined the likelihood of having an eye visit
among those with diabetes, for whom regular retinopathy screening is recommended. We defined CKD status by
average estimated glomerular filtration rate based on two or more creatinine measurements ≥ 3 months apart (no
CKD, ≥ 60 ml/min/1.73 m
2; CKD, < 60 ml/min/1.73 m
2).
Results: Only 11.0% and 17.4% of patients with and without CKD, respectively, had at least one dental visit. Those
with CKD had a 25% lower likelihood of having a dental visit [HR = 0.75, 95% CI (0.64-0.88)] than those without
CKD after adjustment for confounders. Among the subgroup of patients with diabetes, 11.8% vs. 17.2% of those
with and without CKD had a dental visit, while 58.8% vs. 57.8% had an eye visit.
Conclusions: Dental visits, but not eye visits, in a US public healthcare setting are extremely low, particularly
among patients with CKD. Given the emerging association between oral health and CKD, addressing factors that
impede dental access may be important for reducing the disparate burden of CKD in this population.
Background
Chronic kidney disease (CKD) affects an estimated 14%
of the adult US population [1]. Over a half million adults
have progressed to end-stage renal disease, which confers
considerable societal cost—in excess of $30 billion in
2008 [2]—and is the ninth leading cause of death in the
United States [3]. Further, CKD disproportionately affects
racial/ethnic minorities and the poor [4-8]—populations
that are over-represented in public healthcare systems
[9,10]. Prevention of CKD progression is key for reducing
racial-ethnic and socioeconomic disparities and societal
burden of CKD.
Regular dental care may be an important strategy for
preventing CKD progression, given that several studies
have shown individuals with significant periodontal disease
have 1.5- to 2-fold increased odds of CKD, even after
accounting for important confounders such as diabetes,
t o b a c c ou s e ,a n ds o c i o e c o n o m i cs t a t u s[ 1 1 - 1 4 ] .T h o u g h
periodontal disease is a local bacterial infection of the oral
cavity, periodontal pathogens can access systemic circula-
tion [15,16] and potentially induce kidney injury through
an innate immune response. However, in the resource-
poor public healthcare setting, recommended regular pre-
ventive dental care may not be readily accessible. Further,
patients with CKD may be less apt to seek dental care
because of excess appointments and lifestyle modifications
required for CKD management.
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lic healthcare setting, we described dental visits among
adults with and without CKD receiving care in the San
Francisco Department of Public Health Community
Health Network. To determine whether use of dental ser-
vices reflected a uniform approach to preventive service
use in this population, we also described eye visits among
the subgroup with diabetes (a strong risk factor for both
CKD [17] and periodontal disease [18])– for whom reti-
nopathy screening is recommended in standard guide-
lines for diabetes care [19].
Methods
Study design and population
The Health Record Data Service (THREDS) provides long-
itudinal data from electronic clinical databases (Lifetime
Clinical Record and Invision) within the San Francisco
Department of Public Health Community Health Network
for research purposes. The Network is an integrated public
healthcare system that includes federally qualified health
centers and shares an electronic medical record system
with unique patient identifiers to support clinical and
research activities across sites. We requested that
THREDS provide randomly selected cohorts starting in
January 1, 2005 of records from 5,000 adults (≥ 20 years)
with CKD, 5,000 without CKD, and 5,000 of unknown
CKD status. For this study, we included those adults with
and without CKD who had at least two primary care visits
on or after January 1, 2005; and at least 12 months of fol-
low-up before July 31, 2010. This study was approved by
the University of California, San Francisco Committee on
Human Research.
Measurements and definitions
We defined CKD by two outpatient serum creatinine mea-
surements at least 3 months apart associated with an aver-
age estimated glomerular filtration rate (eGFR) < 60 ml/
min/1.73 m
2. No CKD was defined by no creatinine values
associated with eGFR < 60 ml/min/1.73 m
2,o rb yo n e
a b n o r m a lc r e a t i n i n ev a l u ef o l l o w e db yan o r m a lv a l u e .
Unknown CKD status was defined by zero or only one
creatinine measurement. Estimated GFR was calculated
according to the Modification of Diet in Renal Disease
(MDRD) Study equation for calibrated creatinine [20], as
is used clinically in the study population setting for detec-
tion of CKD. Serum creatinine was measured using an
ADVIA chemistry analyzer (Siemens Healthcare Diagnos-
tics, Deerfield, IL) by the Jaffe method before June 2008
and by enzymatic assay after June 2008.
A dental visit was defined as an encounter at any Net-
work dental facility (inpatient or outpatient) at any time
during the study period, which included the time from
study entry (date of second creatinine confirming CKD
status) to last date of follow-up (July 31, 2010) or death.
Similarly, we defined an eye visit as an encounter at any
Network eye facility (inpatient or outpatient) at any time
during the study period. Diabetes was defined by any
International Classification of Diseases, 9
th Revision,
Clinical Modification (ICD-9-CM) diagnostic code in the
medical record for diabetes (250.xx) during the study
period. Periodontal disease was defined by any ICD-9-
CM diagnostic code in the medical record for periodontal
disease (523.xx) or loss of teeth due to periodontal dis-
ease (525.12).
Covariates were defined at study entry. We categorized
self-reported age into three groups (20-45, 46-64, 65+)
and self-reported race/ethnicity as white, black, Latino,
Asian, or other. Language preference was categorized as
English, Spanish, Chinese (Cantonese or Mandarin), or
other. Insurance status was categorized as Medicare, Med-
icaid, or other (city plan, county assistance, self-pay, or
worker’s compensation). Monthly income was categorized
as $0, $1-$500, or $501-$1,000.
Statistical analyses
Patient characteristics were examined by CKD status
using chi-square analyses. Fewer than 10% of the cohort
had more than 1 dental visit during the study period.
Therefore, we fit Cox proportional hazards models to
examine likelihood of having a dental visit by CKD status
at any time during the study period after study entry.
Covariates were added to the unadjusted model in a
sequential fashion with the final model including age
group, gender, race/ethnicity, language preference, insur-
ance, and monthly income.
Additionally, we examined having any dental visit or any
eye visit by CKD status among patients with and without
ICD-9 code for diabetes using chi-square analyses. We
repeated Cox proportional hazard models as above to
separately test the association between time to any dental
visit or any eye visit and CKD by diabetes status. All ana-
lyses were performed with Stata v. 12.0 (StataCorp,
College Station, TX).
Results
We included 2,235 and 4,263 adult (> = 20 years)
patients with and without CKD, respectively, who met
our study criteria. Patient characteristics by CKD status
are shown in Table 1. Patients in the CKD cohort were
more often over age 65, of Asian race/ethnicity, had dia-
betes, and insured by Medicare than those without
CKD.
Although there was a wide range in total number of
dental visits (range 0-46), only 986 (15.2%) of the entire
study population had at least one dental visit over the
observed period. Patients with CKD had a slightly longer
mean follow-up period than those without CKD (4.5 vs.
4.3 years, p < 0.001), but less frequently had a dental visit
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Page 2 of 6(11.0% vs. 17.4%, p < 0.001). Among patients who had a
dental visit, 33.8% and 32.9%, respectively, were diag-
nosed with periodontal disease (p = 0.767).
Adult patients with at least 12 months of follow-up but
unknown CKD status (and therefore not included in the
analysis, n = 3,275) were mostly under age 45 (56.7%),
uninsured (65.8%), and did not have diabetes (90.8%). This
group had a shorter mean follow-up period than those of
known CKD status (3.8 vs. 4.4 years, p < 0.001) but a simi-
lar percentage had a dental visit (14.5% vs. 15.2%, p =
0.403) as those of known CKD status.
In the Cox proportional hazards model, those with
CKD had a 27% lower likelihood of having a dental visit
after adjusting for age [hazard ratio 0.73, 95% CI (0.63,
0.85)]. This association was similar after additionally
adjusting for gender, race/ethnicity, language preference,
insurance, and monthly income [0.75 (0.64-0.88)]
(Table 2).
Of note, in the fully adjusted model, the likelihood of
having a dental visit significantly differed by age and
race/ethnicity, but not insurance (data not shown). Age
46-64 and age over 65 were associated with a 38% [0.72
(0.62-0.83)] and 54% [0.46 (0.37-0.58)], respectively,
lower likelihood of having a dental visit compared to age
20-45. Blacks were nearly twice as likely to have a dental
visit as whites [1.88 (1.57-2.25)], but there was no differ-
ence in likelihood in having a dental visit between whites
and other racial/ethnic groups. Tests for interaction
between CKD status and age group or race/ethnicity
were not significant (pinteraction = 0.281 and 0.091,
respectively).
While the percentage of patients with a dental visit was
similar between those with and without diabetes (14.7%
vs. 15.5%, p = 0.368), significantly more patients with dia-
betes had an eye visit than those without diabetes (58.3%
vs. 26.8, p < 0.001). The percentages of patients with dia-
betes with a dental or eye visit by CKD status are shown
in Figure 1. Among the 1,392 patients with diabetes but
no CKD, 239 (17.2%) had a dental visit while 805 (57.8%)
had an eye visit over the entire study period. Among the
1,183 patients with diabetes and CKD, 139 (11.8%) had a
dental visit and 696 (58.8%) had an eye visit. Similar to the
entire study population, patients with diabetes and CKD
had a 20% lower likelihood of having a dental visit than
those without CKD in the fully adjusted Cox model [0.80,
(0.64-1.00)]. However, there was no difference in likeli-
hood of having an eye visit by CKD status [fully adjusted
model, 1.07, (0.96-1.19)]. As depicted in Figure 2, the
cumulative incidence of time to dental visit by CKD status
is not substantially different in the entire study population
versus the population restricted to those with diabetes by
CKD status. Figure 3 depicts an essentially overlapping
cumulative incidence by CKD status of time to eye visit
among the subpopulation with diabetes.
Discussion
This is the first study, to our knowledge, to examine den-
tal visits by CKD status. Among a population of adult
patients in a public healthcare setting in urban California,
we found that the percentage of patients who had at least






Had dental visit, n (%) 741 (17.4) 245 (11.0) < 0.001
Years follow-up, mean (SD) 4.3 (1.2) 4.5 (1.2) < 0.001
Age group, n (% characteristic) < 0.001
20-45 1,210 (28.4) 215 (9.6)
46-64 2,250 (52.8) 1,011 (45.2)
65+ 803 (18.8) 1,009 (45.1)
Gender, n (% characteristic) 0.001
Male 2,193 (51.4) 1,052 (47.1)
Female 2,070 (48.6) 1,182 (52.9)
Race/Ethnicity, n (% characteristic) < 0.001
White 996 (23.5) 490 (22.1)
Black 1,283 (30.3) 500 (22.6)
Hispanic 893 (21.1) 382 (17.2)
Asian 986 (23.3) 781 (35.2)
Other 80 (1.9) 64 (2.9)
Language, n (% characteristic) < 0.001
English 2,958 (70.4) 1,467 (67.0)
Spanish 568 (13.5) 234 (10.7)
Chinese 443 (10.6) 306 (14.0)
Other 232 (5.5) 182 (8.3)
Diabetes < 0.001
No 2,871 (67.3) 1,052 (47.1)
Yes 1,392 (32.7) 1,183 (52.9)
Insurance, n (% characteristic) < 0.001
Medicare 1,381 (32.4) 1,275 (57.1)
Medicaid 1,226 (28.8) 576 (25.8)
Other 1,654 (38.8) 382 (17.1)
Monthly income < 0.001
$0 1,415 (33.2) 649 (29.0)
$1-$500 1,780 (41.8) 1,060 (47.4)
$501-$1000 1,068 (25.0) 526 (23.5)
Table 2 Hazard ratios for having a dental visit by CKD
status among entire cohort (reference = no CKD)
Hazard Ratio 95% CI P-value
unadjusted 0.60 0.52, 0.69 < 0.001
+ age 0.73 0.63, 0.85 < 0.001
+ gender, race/ethnicity, language 0.76 0.65, 0.88 < 0.001
+ insurance, monthly income 0.75 0.64, 0.88 < 0.001
Grubbs et al. BMC Nephrology 2012, 13:16
http://www.biomedcentral.com/1471-2369/13/16
Page 3 of 6one dental visit during an average of > 4 years of observa-
tion was extremely low overall and that those with CKD
had a 25% lower likelihood of having a dental visit than
those without CKD. We found a similar difference in
likelihood of having a dental visit by CKD status in the
subgroup with diabetes, but no difference in the
likelihood of having an eye visit by CKD status. Further,
while the percentage having a dental visit was not signifi-
cantly different between subgroups with or without dia-
betes, more than twice as many patients with diabetes
than without diabetes had an eye visit.
These findings are important because of the emerging
association between oral health and CKD. Though there
have been no longitudinal studies to our knowledge exam-
ining the association of periodontal disease with incident
or progressive CKD, cross-sectional associations have been
reported [11-14] and its plausibility is supported in the
cardiovascular literature where periodontal disease has
been shown to be an independent risk factor for incident
coronary heart disease [21], periodontal pathogens have
been shown to be able to directly invade human coronary
artery endothelial cells [22], and there is evidence of rever-
sibility of effects on endothelial function [23]. One pro-
posed mechanism for how periodontal pathogens may
induce kidney injury is through toll like receptor 4
(TLR4)–which is one in a group of transmembrane pro-
teins that play a key role in the innate immune response.
TLR4 is found throughout the kidney [24,25] where it can
recognize and bind bacterial lipopolysaccharide coating,
and launch an inflammatory cascade that could lead to
renal dysfunction [24,25]. Because periodontal disease may
contribute to the development and progression of CKD
and because it is preventable and treatable with regular
dental care, a paucity of dental care in the public health-
care setting may be contributing to the disparate burden
of CKD among the poor and racial/ethnic minorities. Our
finding that a periodontal disease diagnosis was common
among those with a dental visit lends support for the
scope of its possible past and future impact.
Several factors may explain our findings. A lack of pub-
lic insurance coverage of dental services undoubtedly cre-
ates a significant barrier to dental care access among the
poor. Those with dental insurance or the ability to pay
out-of-pocket are significantly more likely to utilize den-
tal services than those without such resources [26,27].
Roughly 1 in 3 adults in the United States lacks dental
insurance [28]. A lack of dental insurance is higher
among the poor and medically uninsured [26,29].
Though the majority of our study population had Medi-
care (a federal health insurance program for adults over
age 65 and those who are physically disabled or meet
other special criteria) or Medicaid (a state-managed
health insurance program for low income citizens and
those with special disabilities), Medicare does not cover
basic or routine dental care [30] and provision of adult
dental services is optional for Medicaid programs [31].
While the prevalence of dental insurance among medi-
cally insured adults in the San Francisco Bay area coun-
ties was 79% in the 2003 California Health Interview
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Figure 1 Percentage of patients with diabetes who had at least
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Figure 2 Cumulative incidence of time to dental visit (A)
overall and (B) among those with diabetes.
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Page 4 of 6service dental program and primary public financer of
dental care for more than 8 million low-income, elderly,
and disabled people in California in 2007–eliminated
most of its adult dental benefits in 2009 due to the state’s
budget deficit [33]. Though Denti-Cal coverage was in
place for most of our study period, the program’sd e n t a l
provider reimbursement rates are among the lowest in
the nation and are significantly below the fees charged by
most dentists. Because of these low reimbursement rates
and elimination of adult dental benefits, only 24% of Cali-
fornia’s private dentists currently accept patients with
Denti-Cal, down from 40% in 2003 [33].
Though fear of dental visits is commonplace [34] and
may contribute to the marked differences in percentages
of patients having a dental visit versus an eye visit, a lack
of healthcare provider recommendation and referral for
dental care may also contribute to this finding. In turn,
healthcare provider recommendation may be in part
influenced by guidelines. While the American Diabetes
Association guidelines strongly recommend routine reti-
nopathy screening for patients with diabetes, there is no
such recommendation for routine dental care even
though periodontal disease is known to worsen glycemic
control [35]. On the other hand, healthcare providers in
public healthcare settings may not recommend routine
dental care regardless of guidelines because accepted
referrals may be limited to those with severe–and cov-
ered—dental problems such as oral abscess.
Our finding that having a dental visit varied by CKD
status suggests that patients with CKD may be less
likely to seek preventive dental care because of the bur-
den of extra appointments and lifestyle modifications
required for CKD management that their counterparts
without CKD may not experience. Additionally, the
finding may be partially attributable to out-of-pocket
expenses associated with the extra appointments and
medications specific to CKD management (such as
phosphorus binders and vitamin D analogs). This bur-
den would leave fewer resources for uncovered dental
care expenses, but may not affect covered eye visits, for
which we found no difference by CKD status. Future
research should investigate the barriers to dental care
specific to patients with CKD.
It is important to note that Healthy People 2010 goals
for annual eye and dental examinations among people
with diabetes were 76% and 71%, respectively. In 2005,
57.2% of Californians over age 18 with diabetes reported
they had a dilated eye examination in the past year [36]. In
2006, 66.7% of this population reported a dental examina-
tion within the past year [37]. Our findings that only
58.3% and 14.7% of people with diabetes in our study had
an eye and dental visit, respectively, over an average fol-
low-up of > 4 years underscores the magnitude of barriers
to standard of care in the public healthcare setting.
Our study is not without limitations. First, patients
m a yh a v es o u g h td e n t a lc a r eo u t s i d eo ft h eN e t w o r k .
However, because of the low acceptance of private den-
tists of Medicaid and Medicare, we expect this was an
uncommon occurrence. Also, we would not expect out-
of-network care to differ by CKD status. Second, we did
not have information on dentate status. Edentulous
patients may have less need for dental services and are
not at risk for periodontal disease. Finally, we do not
have information if visits were for routine, preventive
care or for problems requiring urgent attention. Given
the barriers to dental care in the public healthcare set-
ting, the rate of truly preventive dental care is likely
considerably lower.
Conclusion
In conclusion, the percentage of patients with dental
care within a public healthcare setting is strikingly low
overall, but particularly among those with CKD. Given
the emerging association between oral health and CKD,
addressing factors that impede dental access may be
important for reducing the disparate burden of CKD in
this population.
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